Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2025

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Summary of the Company's Warrants Outstanding

The following table is a summary of the Company’s warrants outstanding as of September 30, 2025:

	Number of
	Warrants Outstanding		Exercise Price		Initial Exercise Date	Expiration Date
Pre-Funded Warrants		433,962	$	0.0012	February 13, 2024	Until Exercised in Full
Series A Warrants		354,022	$	8.16	February 13, 2024	February 13, 2029
Modified Series A Warrants(1)		158,531	$	0.01	February 13, 2024	February 13, 2029
Series C Warrants		392,754	$	8.16	February 13, 2024	February 13, 2029
Modified Series C Warrants(1)		250,627	$	0.01	February 13, 2024	February 13, 2029
Representativesʼ Warrants		45,955	$	13.47	August 13, 2024	February 13, 2029
Total warrants		1,635,851

__________________

(1)The Modified Series A Warrants and Modified Series C Warrants represent Series A Warrants and Series C Warrants, respectively, modified under the September 2024 Exercise Price Warrant Amendment.

Summary of Estimated Fair Value of Stock Option Award

The following assumptions were used in estimating the grant date fair value of options issued during the three and nine months ended September 30, 2025 and 2024:

	Three Months Ended September 30,		Nine Months Ended September 30,
	2025	2024	2025	2024
Risk free interest rate	—	3.8-3.9%	4.18-4.39%	3.8-4.5%
Expected option term (in years)	—	5.8-6.0	5.5-6.0	5.5-6.0
Volatility of common stock	—	105.8-106.6%	99.0- 107.3%	105.8-107.1%
Expected dividend yield	—	0.0%	0.0%	0.0%

Summary of Recognized Stock-Based Compensation Expense

The Company recognized stock-based compensation expense as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2025		2024		2025		2024
Research and development	$	727	$	3,016	$	5,101	$	4,231
Selling, general and administrative		104,329		128,571		288,592		507,963
Total stock-based compensation expense	$	105,056	$	131,587	$	293,693	$	512,194

	Three Months Ended September 30,				Nine Months Ended September 30,
	2025		2024		2025		2024
Stock options	$	93,301	$	130,054	$	264,273	$	510,661
ESPP		11,755		1,533		29,420		1,533
Total stock-based compensation expense	$	105,056	$	131,587	$	293,693	$	512,194

ESPP [Member]

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Summary of Estimated Fair Value of Stock Option Award

The estimated fair value of each ESPP award granted was determined on the date of purchase using the Black-Scholes option-pricing valuation model with the following assumptions for the periods presented:

	Three Months Ended September 30,		Nine Months Ended September 30,
	2025	2024	2025	2024
Risk free interest rate	4.0%	4.9%	4.0-4.3%	4.9%
Expected option term (in years)	0.5	0.5%	0.5	0.5
Volatility of common stock	169.1%	91.5%	91.5-169.1%	91.5%
Expected dividend yield	0.0%	0.0%	0.0%	0.0%